DOCSLIB.ORG

Clinical Signs and Symptoms Predicting Influenza Infection

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical Signs and Symptoms Predicting Influenza Infection ORIGINAL INVESTIGATION Clinical Signs and Symptoms Predicting Influenza Infection Arnold S. Monto, MD; Stefan Gravenstein, MD; Michael Elliott, MD; Michael Colopy, PhD; Jo Schweinle, MD Background: New antiviral drugs are available for els to identify those best predicting laboratory confirma- the treatment of influenza type A and type B infec- tion of influenza. tions. In clinical practice, antiviral use has rarely been guided by antecedent laboratory diagnosis. Defined Results: Of 3744 subjects enrolled with baseline influ- clinical predictors of an influenza infection can help enzalike symptoms, and included in this analysis, 2470 guide timely therapy and avoid unnecessary antibiotic (66%) were confirmed to have influenza. Individuals with use. influenza were more likely to have cough (93% vs 80%), fever (68% vs 40%), cough and fever together (64% vs Objective: To examine which clinical signs and symp- 33%), and/or nasal congestion (91% vs 81%) than those toms are most predictive of influenza infection in pa- without influenza. The best multivariate predictors of in- tients with influenzalike illness using a large data set de- fluenza infections were cough and fever with a positive rived from clinical trials of zanamivir. predictive value of 79% (P,.001). The positive predic- tive value rose with the increase in the temperature at Methods: This analysis is a retrospective, pooled analy- the time of recruitment. sis of baseline signs and symptoms from phase 2 and 3 clinical trial participants. It was conducted in mainly un- Conclusion: When influenza is circulating within the vaccinated (mean age, 35 years) adults and adolescents community, patients with an influenzalike illness who have who had influenzalike illness, defined as having fever or both cough and fever within 48 hours of symptom onset feverishness plus at least 2 of the following influenza- are likely to have influenza and the administration of in- like symptoms: headache, myalgia, cough, or sore throat fluenza antiviral therapy may be appropriate to consider. who underwent laboratory testing for influenza. Clini- cal signs and symptoms were evaluated in statistical mod- Arch Intern Med. 2000;160:3243-3247 NFLUENZA VIRUS infection is a ma- lem.14,15 Zanamivir and oseltamivir, new, From the Department of jor public health problem, occur- recently approved antiviral agents, are in- Epidemiology, University ring, typically, in the Northern hibitors of the influenza virus enzyme of Michigan, Ann Arbor Hemisphere, between the months neuraminidase and are active against in- (Dr Monto); Center for of December and April. Epidem- fluenza type A and type B.3,11,12,16 When ad- Geriatrics and Gerontology, Iics of influenza are characterized by an in- ministered early in the course of infec- East Virginia Medical School, creased morbidity and mortality in the tion, both reduce the time to alleviation Norfolk (Dr Gravenstein); and community and result in increased absen- of clinical symptoms in individuals Infectious Diseases and teeism from school and work.1-6 The clas- infected with influenza.3,11,12 Hepatitis, Glaxo Wellcome Inc, sic influenza syndrome is sudden in on- To be maximally effective against in- Research Triangle Park, NC (Drs Elliott, Colopy, and set and is characterized by fever, headache, fluenza, antiviral therapy must be initi- Schweinle). Dr Monto has cough, sore throat, myalgia, nasal conges- ated as soon as possible after symptom on- 3-8 received honoraria and tion, weakness, and loss of appetite. set, and clearly cannot await traditional research support from Glaxo Vaccines, the most cost-effective pri- laboratory diagnosis.11,12,17,18 This analy- Wellcome Inc and mary prevention for influenza, are effec- sis examined which clinical signs and Hoffmann-LaRoche Inc. tive and readily available but have their symptoms are most predictive of influ- Dr Gravenstein is a consultant limitations.9,10 Two antiviral agents with enza infection in patients with influenza- to Glaxo Wellcome Inc and similar activity, amantadine hydrochlo- like illness using a large data set derived Hoffmann-LaRoche Inc and has ride and rimantadine hydrochloride, have from clinical trials of zanamivir. Knowl- received research support from been available many years for prophy- edge of the most predictive symptoms Glaxo Wellcome Inc. 3,10-13 Drs Elliott, Colopy, and laxis and treatment of influenza. How- of influenza could be used by physicians Schweinle are employee of ever, both of these agents are active only to diagnose influenza more accurately and Glaxo Wellcome Inc and may against influenza type A and not influ- to begin an appropriate course of treat- hold Glaxo Wellcome stock enza type B, and resistance of influenza ment in time to be of most benefit to the or stock options. A viruses to these drugs can be a prob- patient. (REPRINTED) ARCH INTERN MED/ VOL 160, NOV 27, 2000 WWW.ARCHINTERNMED.COM 3243 ©2000 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/24/2021 PATIENTS AND METHODS DATA COLLECTION AND ANALYSIS The following baseline signs or symptoms were analyzed as STUDIES AND DESIGN potential predictors of influenza infection: fever, feverishness, cough, headache, sore throat, myalgia, nasal congestion, weak- Eight double-blind, placebo-controlled studies involving ness, and loss of appetite. Although the symptoms were col- 231 study centers in North America, Europe, and the South- lected using a 4-point severity scale, for this analysis they were ern Hemisphere were included in this analysis (Table 1). analyzed as either absent or present. A diagnosis of influenza These studies were phase 2 and 3 clinical trials designed was defined either as a positive culture for influenza virus or to evaluate the use of the antiviral agent zanamivir vs pla- as a 4-fold or greater increase in influenza antibody titer in cebo for the treatment of influenza type A and type B viral convalescent vs acute serum samples as determined by hem- infections and were conducted during the fall and/or win- agglutination inhibition. In some studies, influenza infection ter of 1994 through 1998. could also or alternatively be confirmed by polymerase chain Data regarding patients’ signs and symptoms, col- reaction (NAIA/B3002 [the protocol report number]) or by lected at baseline (ie, prior to any treatment), were immunofluorescence.19,20 pooled across the 8 studies. All available study data were Univariate and multivariate analyses were conducted to included in the analysis to minimize the potential for compare clinical signs and symptoms with the diagnosis of bias. influenza. Demographic factors such as age, sex, high-risk populations (defined as having chronic respiratory disease, PATIENTS cardiovascular disease, or more advanced age [ie, $65 years old]), and hours from symptom onset to collection of the di- To be eligible, study participants were required to have fe- agnostic specimen were also incorporated into the analysis. ver (body temperature $37.8°C or $37.2°C for patients A stepwise logistic regression analysis was performed to de- $65 years old in NAIA/B3002 [the protocol report num- termine which baseline symptoms and patient characteris- ber]) or a symptom of feverishness, plus at least 2 of the tics best predict influenza infection. The stepwise procedure following influenzalike symptoms: headache, myalgia, selected the best explanatory variable into the model first, then cough, or sore throat. Feverishness was defined as the pa- selected the second best explanatory variable, and so forth. tient’s subjective symptom of feeling like they had a fever The stepwise procedure stopped selecting additional vari- or chill. Specific influenzalike symptoms required for pa- ables when they did not reach statistical significance at the tient enrollment into each study are also summarized by a=.05 level, given the other variables already in the model. study in Table 1. The stepwise logistic regression model was tested for good- A requirement for a study site to begin patient ness of fit to determine the most parsimonious model. Odds enrollment was the identification of at least 2 individuals ratios and their 95% confidence intervals were calculated for with culture-confirmed influenza within a 7-day period each variable in the logistic regression model. Measures of prior to enrollment, who resided in the geographic positive predictive value (PPV), negative predictive value, region around the site. Geographic region was defined as sensitivity, and specificity were calculated to also identify the the area within a 50-mile radius of the study location. best predictors of an influenza infection. Positive predictive This requirement was to improve the probability that values were compared for individual symptoms, as well as influenza was actually present in the geographic region combinations of symptoms (SAS Statistical Analysis Soft- of the study. ware, version 6.12; SAS Institute Inc, Cary, NC). RESULTS model, with fever (odds ratio=3.26; P,.001) and cough (odds ratio=2.85; P,.001) as the 2 best explanatory vari- A total of 3744 clinical trial participants with influenza- ables. Headache, myalgia, and high-risk status were poor like symptoms were enrolled during the fall and/or winter explanatory variables (P..05) and were not selected into of 1994 through 1998. Demographic information of study the model. Feverishness was not included since fever (body participants, the percentage who had been vaccinated against temperature $37.8°C) was already in
Load more

Recommended publications
  • Bronchiolitis
    6 Sand Hill Road, Suite 102 Flemington, NJ 08822 PHONE 908-782-6700 FAX 908-788-5861 hunterdonpediatrics.org BRONCHIOLITIS Bronchiolitis is an infection of the small breathing tubes (bronchioles) that lead to the lung. Bronchiolitis is not the same as bronchitis, which is an infection in the large breathing tubes (bronchi). Bronchiolitis is usually seen in infants and young toddlers. It is not usually seen in older children or adults. A virus causes bronchiolitis. The most common virus is RSV (respiratory syncytial virus). Since RSV infection does not usually result in immunity, people can get it again; however, beyond the age of two, RSV usually causes just a bad cold. RSV is very contagious and spreads rapidly through childcare groups and families from October through April. Some studies suggest that babies who get RSV are more likely to have asthma in the future. Also, people with asthma who get RSV infection may trigger an asthma attack. Babies with RSV have severe nasal congestion, usually followed by a worsening cough. There may be a mild fever at the beginning of the illness. Signs of trouble with RSV include: ● Poor feeding/decreased urine output ● Rapid breathing ● Grunting sound with breathing ● Tightening of chest or stomach muscles with breathing ● Wheezing (high pitched whistling sound with breathing out) ● Blue tint around mouth or fingers/toes ● Fever lasting more than two days, or over 104 The vast majority of patients with bronchiolitis recover well. Certain children are especially likely to have trouble with bronchiolitis: ● Infants under two months of age ● Infants who were premature and have not reached their “due date” yet ● Patients with lung diseases like cystic fibrosis or bronchopulmonary dysplasia (BPD) ● Patients with severe heart disease ● Patients with AIDS or other immunity problems ● Patients on chemotherapy or with organ transplants Treatment for bronchiolitis is mostly supportive; that is, treatment is aimed at helping the patient breathe better.
    [Show full text]
  • The Common Cold.Pdf
    PATIENT TEACHING AID The Common Cold PERFORATION ALONG TEAR Everyone has experienced the misery of the common Rhinovirus Infection cold. A cold causes familiar symptoms such as a runny nose, sore throat, congestion, postnasal drip, and cough. For most sufferers, these symptoms are annoying, but not serious. Cold symptoms gradually improve and disappear over 7 to 10 days without complications. Colds are viral infections, so treatment with an antibiotic is not helpful. The best treatment for a cold is rest, fluids, and nonprescription medicines to help relieve symptoms. Although there is no vaccine to prevent colds, the spread of cold viruses can be slowed by frequent hand washing and avoiding close contact with those suffering from a cold. ILLUSTRATION: KRISTEN WIENANDT MARZEJON 2016 MARZEJON WIENANDT KRISTEN ILLUSTRATION: Copyright Jobson Medical Information LLC, 2016 continued MEDICAL PATIENT TEACHING AID Antibiotics Should Not Be Used to Treat a Cold Colds are caused by a variety of viruses, most commonly rhinoviruses. These viruses are highly contagious, and they are spread through the air or when someone is in contact with an infected person or contaminated object. There is no good evidence that exposure to cold or being overheated © Jobson Medical Information LLC, 2016 LLC, Information Medical Jobson © increases the risk of contracting a cold. Although most Wash your hands thoroughly and frequently colds occur in the winter months, some viruses that cause to prevent the spread of cold viruses. colds are more common in the fall or spring. Infants and young children are more prone to colds, as are people with weakened immunity.
    [Show full text]
  • SEPTOPLASTY SURGICAL INFORMED CONSENT the Nasal
    .SEPTOPLASTY SURGICAL INFORMED CONSENT The nasal septum is the wall inside your nose that divides it into two separate nasal passages. It is made of cartilage and bone. In a healthy nose, there is usually nearly equal airflow on both sides. Sometimes, the nasal septum is crooked or twisted. This condition is called a deviated nasal septum, and it can be caused by trauma to the nose, or patients can be born this way. The primary problem with a deviated nasal septum is nasal blockage, either on one or both sides. This nasal blockage can also contribute to nosebleeds, sinus infections, and often worsens obstructive sleep apnea. Occasionally, a deviated septum can be associated with a specific type of headache. A deviated septum can be surgically repaired with an operation called a septoplasty. This is typically done through a closed approach, which takes about one hour. More complicated or severely deviated septa may require an open approach, which can take up to 2-3 hours. In either case, septoplasty surgery is done under general anesthesia. It is an outpatient procedure so patients will be discharged home the same day. Some patients have multiple causes of nasal obstruction. Aside from a deviated septum, other reasons for a stuffy nose include chronic sinusitis, turbinate hypertrophy, nasal polyps, or nasal valve collapse. In these cases, septoplasty surgery may be performed in conjunction with other procedures such as endoscopic sinus surgery, turbinate reduction, or insertion of alar batten or spreader grafts. These procedures are discussed in their own individual sections on our website. Your physician will discuss what surgery is most appropriate for you.
    [Show full text]
  • Allergic/Non-Allergic Rhinitis
    Tips to Remember: Rhinitis Do you have a runny or stuffy nose that doesn't seem to go away? If so, you may have rhinitis, which is an inflammation of the mucous membranes of the nose. Rhinitis is one of the most common allergic conditions in the United States, affecting about 40 million people. It often coexists with other allergic disorders, such as asthma. It is important to treat rhinitis because it can contribute to other conditions such as sleep disorders, fatigue and learning problems. There are two general types of rhinitis: Allergic rhinitis is caused by substances called allergens. Allergens are often common, usually harmless substances that can cause an allergic reaction in some people. Causes • When allergic rhinitis is caused by common outdoor allergens, such as airborne tree, grass and weed pollens or mold, it is called seasonal allergic rhinitis, or "hay fever." • Allergic rhinitis is also triggered by common indoor allergens, such as animal dander (dried skin flakes and saliva), indoor mold or droppings from cockroaches or dust mites. This is called perennial allergic rhinitis. Symptoms • Sneezing • Congestion • Runny nose • Itchiness in the nose, roof of the mouth, throat, eyes and ears Diagnosis If you have symptoms of allergic rhinitis, an allergist/immunologist can help determine which specific allergens are triggering your reaction. He or she will take a thorough health history, and then test you to determine if you have allergies. Skin tests or Blood (RAST) tests are the most common methods for determining your allergic triggers. Treatment Once your allergic triggers are determined, your physician or nurse will work with you to develop a plan to avoid the allergens that trigger your symptoms.
    [Show full text]
  • (RSV) Infection? an Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database
    Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database Barbara J. Law, MD*; Elaine E. L. Wang, MDCM‡; Noni MacDonald, MD§; Jane McDonald, MDi; Simon Dobson, MD¶; Francois Boucher, MD#; Joanne Langley, MD**; Joan Robinson, MD‡‡; Ian Mitchell, MD§§; and Derek Stephens MSc‡ ABSTRACT. Objectives. To determine the relation- 20.6%, 20.9%, 15.5%, 15.2%, and 13.3%, respectively. ship between receipt of aerosolized ribavirin and the Across the subsets ribavirin use ranged from 36% to 57% hospital course of high-risk infants and children with of ventilated patients and 6% to 39% of nonventilated respiratory syncytial virus (RSV) lower respiratory infec- patients. For nonventilated patients in each subset the tion (LRI). median RSV-attributable hospital length of stay (RSV- Methods. The 1993–1994 Pediatric Investigators Col- LOS) was 2 to 3 days longer for ribavirin recipients and laborative Network on Infections in Canada (PICNIC) the duration of hypoxia was significantly increased. Du- RSV database consists of prospectively enrolled children ration of intensive care unit (ICU) stay was also increased with acute RSV LRI, admitted to nine Canadian pediatric for all ribavirin-treated subgroups except those with tertiary care centers. After excluding cases with compro- CHD. In contrast, for ventilated patients, ribavirin ther- mised immunity and/or nosocomial infection, subsets apy was
    [Show full text]
  • Anorexia/Cachexia Heart Failure Symptom Management Guideline for Adults, Age 19 and Older in British Columbia
    Anorexia/Cachexia Heart Failure Symptom Management Guideline For adults, age 19 and older in British Columbia What is anorexia? Anorexia is a syndrome characterized by some or all of the following symptoms: loss of appetite, nausea, early satiety, weakness, fatigue, food aversion, and significant physical and/or psychological symptoms. Causes of anorexia are multifactorial and include fatigue, dyspnea, medication side-effects, nausea, depression, anxiety and sodium restricted diets, which may all be found in patients with heart failure. What is cachexia? Cachexia is a syndrome characterized by severe body weight, fat and muscle loss and increased protein catabolism due to underlying disease. The prevalence of cachexia is 16–42% in the heart failure population and is associated with a 50%, 18 month mortality risk independent of variables such as ejection fraction, age and functional ability. How is cachexia diagnosed? Chronic condition with >5% weight loss in <12 months; or body mass index (BMI) <20kg/m2; and 3 out of 5 additional criteria: 1) Fatigue, 2) Decreased muscle strength, 3) Anorexia, 4) Low muscle mass, 5) Abnormal biochemistry *Blood testing to diagnose cachexia in advanced stages of disease is not advocated. Reminder: Malnutrition also affects prognosis in patients with heart failure and is often found in early transitions of the disease. However this symptom management guideline will focus on the assessment and treatment of anorexia and cachexia. Approach to Managing Anorexia/Cachexia Assessment History: When did weight loss begin? How much weight was lost? Obtain baseline (dry) weight. How is [the patients] appetite? What do they eat or drink on a typical day? How has weight loss affected mood? Ask about: nausea, early satiety, dyspnea, poor oral hygiene, dysphagia, malabsorption, bowel habits.
    [Show full text]
  • Influenza (PDF)
    INFLUENZA Outbreaks of influenza, or “flu”, typically occur every winter. Colds may occur at any time of year with seasonal peaks occurring in fall and spring. Influenza is a respiratory illness usually caused by infection with one of two influenza viruses – influenza A or influenza B. Outbreaks of influenza (flu) typically occur every winter. Influenza is characterized by an abrupt onset of fever, chills, headache, body aches, and lack of energy accompanied by respiratory symptoms, most frequently cough and sore throat. Most people are largely recovered in one week, although many feel fatigued for several weeks. Serious complications of flu, such as pneumonia, however, can occur, especially if the body’s defenses are weakened by age or disease. Influenza is spread by inhaling the influenza virus which is usually carried on tiny, invisible water droplets in the air generated by coughs and sneezes. Hand-to-hand contact as well as contact with infected secretions on a hard surface may also cause transmission of the virus. Each year influenza viruses change and new vaccines are made to combat the particular strains that are expected to cause illness that year. The flu vaccine may reduce the chance of getting the flu by 60-80%, and lessen the severity of illness in the person who does get the flu. According to the Centers for Disease Control (CDC), everyone 6 months or order should get a yearly flu vaccine. The following people are at high risk for complications of flu and are especially urged to get vaccinated: Individuals with chronic heart or lung problems that have required regular medical follow-up or hospitalization during the last year.
    [Show full text]
  • Bronchiolitis
    Bronchiolitis What is bronchiolitis? Bronchiolitis is a viral infection of the lungs that usually affects infants. There is swelling in the smaller airways or bronchioles of the lung, which causes coughing and wheezing. Bronchiolitis is the most common reason for children under 1 year old to be admitted to the hospital. What are the symptoms of bronchiolitis? The following are the most common symptoms of bronchiolitis. However, each child may experience symptoms differently. Symptoms may include: Runny nose or nasal congestion Fever Cough Changes in breathing patterns (wheezing and breathing faster or harder are common) Decreased appetite Fussiness Vomiting What causes bronchiolitis? Bronchiolitis is a common illness caused by different viruses. The most common virus causing this infection is Respiratory Syncytial Virus (RSV). However, many other viruses can cause bronchiolitis including: Influenza, Parainfluenza, Rhinovirus, Adenovirus, and Human metapneumovirus. Initially, the virus causes an infection in the upper airways, and then spreads downward into the lower airways of the lungs. The virus causes swelling of the airways. Mucus is also produced in the airways. This narrowing of the airways can make it difficult for your child to breath, eat, or nurse. How is bronchiolitis diagnosed? Bronchiolitis is usually diagnosed on the history and physical examination of the child. Antibiotics are not helpful in treating viruses and are not needed to treat bronchiolitis. Because there is no cure for the disease, the goal of treatment is to make your child comfortable and to support their symptoms. This treatment may include suctioning to keep the airways clear, extra oxygen if the blood oxygen levels are low, or hydration if your child is not able to feed well.
    [Show full text]
  • New Medical Treatments for Nasal Polyps
    New Medical Treatments for Nasal Polyps February 7, 2020 Brian Modena, MD, MSc 1 Disclosures Research support: NHLBI‐Supported Researcher Self Care Catalysts: architect of Health StorylinesTM app Personal Fees: AstraZeneca, GSK, Regeneron, Sanofi 42nd Annual Pulmonary and Allergy Update Objectives 1. Discuss the epidemiology, biology, pathophysiology, and symptoms of CRS with nasal polyposis (CRSwNP). 2. Review treatment guidelines and recommendations for CRSwNP. 3. Review the many scoring systems used to evaluate CRSwNP. 4. Discuss in detail the Phase II and Phase III clinical trials using biologics for treatment of CRSwNP. Nasal Polyposis Epidemiology Prevalence = ~4%1; (CRS = ~11‐12%)2 Costs: Genetic inheritance = ~14% 2 Increases with age; peak ~50 years CRS = ~$8 billion/year Caucasians = Th2‐driven inflammation. Per patient per year: $13,000; Male to female = 2:1 $26,000 if surgery performed. Asians = Th1‐driven inflammation. Association with allergic rhinitis is weak. Surgeries/year = ~500,000 Disease Prevalence estimates 1. Hastan, Fokkens, et al, 2011 Allergic rhinitis Adult: 0.1%; Children 1.5%1 2. Lange, Holst, et al., Clin Otolaryngol 2013. 3. Mygind. JACI. 1990 Dec;86(6 Pt 1):827‐9. Asthma 5‐22% 4. Schleimer RP. Annu Rev Pathol. 2017;12:331‐57. 5. Hunter TD, DeConde AS, Manes RP. J Med Econ. 2018;21(6):610‐5. CRS 20‐25%1‐4 6. Palmer JN, Messina JC, Biletch R, et al. Allergy Asthma Proc. 2018;39:1‐9. NSAID intolerance 36‐72% 7. Pearlman AN, Chandra RK, Chang D, et al. Am J Rhinol Allergy. 2009;23(2):145‐8. NSAID intolerance and asthma 80% 8.
    [Show full text]
  • Frequently Asked Questions About Sinusitis Table of Contents
    FREQUENTLY ASKED QUESTIONS ABOUT SINUSITIS TABLE OF CONTENTS Chapter 1: Do I have acute sinusitis or chronic sinusitis? 3 Chapter 2: Do I need antibiotics for my acute sinusitis? 4 Chapter 3: What kind of chronic sinusitis do I have? 5 Chapter 4: Why do I have chronic sinusitis? 7 Chapter 5: What are my treatment options for chronic sinusitis? 9 Chapter 6: When should I consider surgery? 11 Chapter 7: Are my allergies causing my chronic sinusitis? 12 Chapter 8: Is there a connection between chronic sinusitis and asthma? 13 Chapter 9: What can I do to keep my chronic sinusitis under control? 14 Chapter 10: About Metropolitan ENT & Facial Plastic Surgery 15 DISCLAIMER: This information is for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this e-book. While all attempts have been made to verify information provided in this publication, the Publisher assumes no responsibility for errors, omissions, or contrary interpretation of the subject matter herein. The content of this e-book was developed and published by eos Healthcare Partners, LLC. Accordingly the information and material in this book is copyright, 2015 © eos Healthcare Partners, LLC.Therefore no part of this book may in any form be reproduced, stored, broadcast, sold or transmitted without the prior permission of the publisher, eos Healthcare Partners, LLC.
    [Show full text]
  • Myalgia As the Revealing Symptom of Multicore Disease and Fibre Type Disproportion Myopathy C Sobreira*, W Marques Jr, a a Barreira
    1317 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.74.9.1317 on 21 August 2003. Downloaded from SHORT REPORT Myalgia as the revealing symptom of multicore disease and fibre type disproportion myopathy C Sobreira*, W Marques Jr, A A Barreira ............................................................................................................................. J Neurol Neurosurg Psychiatry 2003;74:1317–1319 toms of CFTDM are more uniform. However, some patients Background: Multicore disease and congenital fibre type exhibit unusual phenotypes such as rigid spine syndrome,10 11 disproportion myopathy are diseases assigned to the significant dysmorphic features,12 or very mild symptoms.13 heterogeneous group of congenital myopathies. Although Cramps are uncommon complaints in patients with multi- hypotonia and muscle weakness appearing in early life core disease or CFTDM and exercise related muscle pain has are the commonest manifestations of these diseases, not been associated with multicore disease. Aimed at contrib- distinct phenotypes and late onset cases have been uting to better delineating the phenotypic expression of these described. myopathies, we present the clinical cases of patients suffering Objective: To report the occurrence of myalgia as the late onset, generalised muscle pain, whose muscle biopsies revealing symptom of multicore disease and fibre type dis- revealed the distinguishing features of either multicore proportion myopathy. disease or CFTDM. Methods: The clinical cases of three patients with fibre type disproportion myopathy and one with multicore CASE REPORTS disease are described. Skeletal muscle biopsies were Patient 1 processed for routine histological and histochemical A 24 year old man was referred to a neurologist owing to studies. exercise related myalgia involving both the upper and lower Results: The clinical picture was unusual in that the symp- limbs.
    [Show full text]
  • Influenza Vs. Cold Vs. Pertussis
    Influenza vs. Cold vs. Pertussis Symptom Influenza ("Flu") Colds (Viral URI) Pertussis Usually present & high (102-104°F or Uncommon Uncommon Fever 39-40°C); typically lasts 3-4 days If present, typically low-grade If present, typically low-grade Chills Common Uncommon Rare Headache Very common Uncommon Uncommon Aches and pains, muscle Very common Slight to Moderate Uncommon aches, chest discomfort Often severe Mild; Moderate - severe; Fatigue and weakness Mild Usually appears well between can last up to 14-21 days coughing attacks Extreme exhaustion Very common early in illness Extremely Rare Rare Stuffy or runny nose Common Very common Common, early in the disease Sneezing Sometimes Common Common, early in the disease Sore throat Common Common Uncommon Variable character; fits / paroxysms and Hacking cough, often nocturnal cough are common; generally Non-productive ("dry") cough is Character productive; usually responds to not responsive to cough medications; typical cough medications "whooping" may or may not occur Variable; mild to severe; Severity Moderate Mild to Moderate infants appear quite ill and may present Cough with cough or apnea Persistent cough, almost always >1 Typically 3-7 days; Duration Typically 3-7 days week, usually 2-6 weeks, sometimes occasionally to 14 days 10+ weeks Paroxysms Common; Uncommon Rare (coughing fits) often leads to vomiting or gagging From start of catarrhal phase (before 1 day before symptom onset Variable; typically 4-7 days after cough) to 21 days after cough onset* Infectious Period and 3-7 days after symptom onset; can be longer Most efficient spreading after cough onset *or until taking 5 days of appropriate anti-pertussis antibiotics Iowa Department of Public Health 12/10/04.
    [Show full text]